This tumescence ensures an intratissular compression of learn more the injected vessels for at least 1 hour. Results In the last 6 years, we have treated more than 300 patients. Telangiectasias that had resisted several previous

treatments faded or disappeared in the majority of the cases treated, but the rate of complications (pigmentation, necrosis of small areas, and tiny scars) was higher than with usual sclerotherapy. Conclusion Developed after observing the good results achieved by perioperative sclerotherapy of telangiectasias during ambulatory phlebectomy, the START technique is an effective and economic treatment of therapy-resistant telangiectasias, although because the rate of complications is higher than with usual sclerotherapy of C1 veins, it should be performed only by experienced phlebologists and only on therapy-refractory vessels.”
“Study Design. Database study using Nationwide Inpatient Sample (NIS) administrative data from 1993 to 2002.

Objective. To determine rates of in-hospital complications and complex disposition for patients undergoing posterior lumbar fusion for

degenerative spondylolisthesis, and the association of demographic factors.

Summary of Background Data. Spondylolisthesis affects primarily elderly populations. Recent data suggests a benefit of surgical treatment for acquired lumbar spondylolisthesis. However, the risks this website of these procedures, and the impact of patient demographics on risk, have not been nationally quantified.

Methods. Data from 66,601 patients in the NIS (1993 2002) with diagnostic and procedure codes specifying posterior lumbar fusion for acquired spondylolisthesis were included. Patients were grouped by age, sex, race, number of comorbidities, hospital Sapitinib manufacturer size, and time period of procedure. Multivariate analysis correlated patient and hospital characteristics with complex disposition and complications.

Results. Mortality rate was 0.15%. Eleven percent of patients had one or more in-hospital complications;

overall complication rate was 13 per 100 operations. Hematoma/seroma (5.4 per 100) was the most common complication, followed by pulmonary (2.6), renal (1.8), and cardiac (1.2) complications. Infection and neurologic injury occurred in <1% of patients. Older patients and those with a number of comorbidities had greater rates of inhospital complication and complex disposition. Compared to those aged 45 to 64, patients aged 65 to 84 were almost 70% more likely to have complications (OR: 1.67) and 5 times as likely to have complex disposition (OR: 5.84). Having 3 or greater comorbidities, compared to no comorbidities, was also associated with increased risk of complication (OR: 1.6) and complex disposition (OR: 2.3).